Liquidia Corp. (LQDA)
55.96
-0.67
(-1.18%)
USD |
NASDAQ |
Nov 20, 10:20
Liquidia Cash from Operations (Quarterly) : 146.68M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 146.68M |
| June 30, 2026 | 80.24M |
| March 31, 2026 | 52.99M |
| December 31, 2025 | 44.24M |
| September 30, 2025 | -9.77M |
| June 30, 2025 | -39.48M |
| March 31, 2025 | -30.68M |
| December 31, 2024 | -20.81M |
| September 30, 2024 | -25.08M |
| June 30, 2024 | -22.66M |
| March 31, 2024 | -24.87M |
| December 31, 2023 | -15.98M |
| September 30, 2023 | -11.56M |
| June 30, 2023 | -5.564M |
| March 31, 2023 | -8.457M |
| December 31, 2022 | -4.603M |
| September 30, 2022 | -5.774M |
| June 30, 2022 | -8.429M |
| March 31, 2022 | -9.782M |
| December 31, 2021 | -7.559M |
| Date | Value |
|---|---|
| September 30, 2021 | -5.830M |
| June 30, 2021 | -8.260M |
| March 31, 2021 | -12.39M |
| December 31, 2020 | -14.09M |
| September 30, 2020 | -12.51M |
| June 30, 2020 | -13.11M |
| March 31, 2020 | -14.44M |
| December 31, 2019 | -14.06M |
| September 30, 2019 | -11.95M |
| June 30, 2019 | -12.16M |
| March 31, 2019 | -10.11M |
| December 31, 2018 | -8.329M |
| September 30, 2018 | -6.280M |
| June 30, 2018 | -7.222M |
| March 31, 2018 | -10.00M |
| December 31, 2017 | -4.662M |
| September 30, 2017 | -5.253M |
| June 30, 2017 | -5.333M |
| March 31, 2017 | -9.042M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| United Therapeutics Corp. | 306.50M |
| Johnson & Johnson | 7.72B |
| Eli Lilly & Co. | 11.40B |
| Mentari Therapeutics, Inc. | -1.142M |
| Corcept Therapeutics, Inc. | 142.89M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -16.90M |
| Cash from Financing (Quarterly) | -17.87M |
| Free Cash Flow | 291.15M |
| Free Cash Flow Per Share (Quarterly) | 1.450 |
| Free Cash Flow to Equity (Quarterly) | 143.91M |
| Free Cash Flow to Firm (Quarterly) | 132.33M |
| Free Cash Flow Yield | 5.80% |